İndir Oncology Nursing Drug Handbook - v3.5.13

Lütfen Tıp kategorisindeki öne çıkan Uygulamalar öğelerden biri olan Oncology Nursing Drug Handbook - v3.5.13 'ı indirin ve paylaşın.
Ayrıca, Pacify, Dexcom G6, MCQ Abubakr (ASU), ALAT, NYP, Medical Dictionary Free & Offline - Diseases olarak indirebileceğiniz başka Uygulamalar bazılarını. Oncology Nursing Drug Handbook - v3.5.13 'dan memnunsanız.

Skyscape Medpresso Inc tarafından yayınlanan Oncology Nursing Drug Handbook - v3.5.13, bugün mevcut olan en iyi ücretsiz ve en iyi cep telefonu uygulamalarından biridir. Uygulama mağazasının Tıp kategorisinde yer almaktadır.

Oncology Nursing Drug Handbook - v3.5.13 için minimum işletim sistemi Android 5.0+ ve üstü. Bu nedenle, henüz yapmadıysanız telefonunuzu güncellemeniz gerekir.

APKDroid'de, en son sürümü 3.5.13, yayınlanma tarihi 2020-06-25 ve dosya boyutu 8.4 MB olan Oncology Nursing Drug Handbook - v3.5.13 APK'yı ücretsiz indireceksiniz.Google Play Store'dan alınan istatistiklere göre, yaklaşık 1000 indirme var. Android'e ayrı ayrı indirilen veya yüklenen uygulamalar dilerseniz güncellenebilir. Uygulamalarınızı da güncelleyin. Size en yeni özelliklere ve güvenliğe erişim sağlar ve uygulamanın kararlılığı. Şimdi keyfini çıkarın !!!

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity